Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A highly unusual right atrial mass presented in two women.

European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology·2008
Same author

Differential value of left atrial systolic and diastolic volumes as independent predictors of congestive heart failure or early death in acute myocardial infarction.

Heart (British Cardiac Society)·2006
Same author

Right atrial mass.

The Canadian journal of cardiology·2002
Same author

The importance of age and obesity on the relation between diabetes and left ventricular mass.

Journal of the American College of Cardiology·2001
Same author

Impact of obstructive sleep apnea on left ventricular mass and diastolic function.

American journal of respiratory and critical care medicine·2001
Same author

Glucose and insulin metabolism are important determinants of left ventricular mass in obese hypertensives.

The Canadian journal of cardiology·2000

相关实验视频

Updated: Jul 14, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
06:13

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

抗高血压治疗对葡萄糖和胰岛素代谢以及左心室质量的影响:对21名肥胖高血压患者进行随机,双盲,受控研究.

R Kuperstein1, Z Sasson

  • 1Division of Cardiology, Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Canada.

Circulation
|October 12, 2000
PubMed
概括

佩林多普里尔有效控制了血压和改善了葡萄糖代谢,导致肥胖高血压患者左心室质量减少. 阿提诺洛还降低了血压,但恶化了葡萄糖和胰岛素水平,但没有影响左心室质量.

更多相关视频

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

相关实验视频

Last Updated: Jul 14, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
06:13

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults

Published on: December 1, 2023

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

科学领域:

  • 心脏病学 心脏病学
  • 代谢综合征是代谢综合征的一种.
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 葡萄糖和胰岛素水平与胰岛素耐药个体的左心室质量 (LVM) 相相关.
  • 抗高血压药物对葡萄糖和胰岛素代谢 (GIM) 和LVM具有多种影响.
  • 调查抗高血压治疗对LVM和GIM的影响之间的联系至关重要.

研究的目的:

  • 为了比较阿提诺洛尔和印布里尔对LVM和GIM的影响.
  • 为了确定抗高血压治疗对LVM的影响是否与其对GIM的影响有关.
  • 为了评估胰岛素抵抗性,肥胖的高血压患者的这些影响.

主要方法:

  • 21名肥胖,非糖尿病高血压患者 (年龄55±12岁,BMI 32.8±5.0 kg/m2) 被随机分组.
  • 治疗组接受了阿提诺洛尔 (n=11) 或印普里尔 (n=10) 6个月.
  • 测量包括通过静脉注射葡萄糖耐受性测试进行心声回声 LVM/身高和GIM.

主要成果:

  • 亚特诺洛尔和大兴都有效地降低了血压.
  • 阿提诺洛尔显著恶化了GIM参数 (禁食葡萄糖,胰岛素水平) (P≤0.03).
  • 佩林多普里尔没有影响GIM,并且显著降低了LVM/身高 (P=0.04),而阿提诺洛尔没有 (P=0.8).

结论:

  • 在肥胖的高血压患者中,大兴和阿提诺洛尔实现了类似的血压控制.
  • 与阿提诺洛尔相比,佩林多普利尔显示出更有利的GIM概况.
  • 佩林多普里尔治疗导致左心室质量的显著回归,与阿诺洛尔不同.